all-trans-retinol/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
No detected effect on all-cause mortality
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull resultreplicated ×2“Similarly, mortality at 12 months (n=29 435) of age was not different between the vitamin A and placebo groups; relative risk 1·04 (95% CI 0·93–1·17; p=0·494).”
Quoted verbatim from Effect of neonatal vitamin A supplementation on mortality in infants in Tanzania (Neovita): a randomised, double-blind, placebo-controlled trial.. - Study
- RCT
- Participants
- 29,435
- Duration
- 12 months
- Dose
- single dose of 50,000 IU vitamin A
- Population
- Newborn infants in Tanzania randomised in the first 3 days of life to one 50,000 IU vitamin A dose or placebo; mortality to 12 months of age
Effect 1.04 risk ratio, 95% CI 0.93 to 1.17
Effect of neonatal vitamin A supplementation on mortality in infants in Tanzania (Neovita): a randomised, double-blind, placebo-controlled trial.2015PMID:25499543Permalink
Keep reading
- Everything the graph holds on all-trans-retinol
- Every compound studied against All-cause mortality
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M5JX1TAKSRWFK0VETJEH6SSD